{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T20:50:41Z","timestamp":1786395041103,"version":"build-2736575974"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Osteoclast-rich undifferentiated carcinoma of the urinary tract, herein referred to as urothelial carcinoma with osteoclast-like giant cells (UCOGC), is a rare tumor currently classified under the \u201cpoorly differentiated urothelial carcinoma\u201d subtype. This study aimed to evaluate the clinicopathologic, immunophenotypic, and molecular features of UCOGC to better characterize its origin and support its classification as a unique subtype.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>There were 14 UCOGCs studied with immunohistochemistry\/in situ hybridization and compared to urothelial carcinomas with trophoblastic differentiation (n\u2005=\u20056) and giant cell urothelial carcinomas (n\u2005=\u20055). Markers were assessed in mononuclear (MN) and giant cell (GC) components. Next-generation sequencing was performed on 4 UCOGCs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The MN cells of UCOGC demonstrated high expression of CD68, CD163, SATB2, cathepsin K, and CSF1 in situ hybridization (ISH), with moderate staining for GATA3, p63, and PU.1 and low staining for pankeratin. The GCs showed high CD68, PU.1, and cathepsin K expression but low CD163, SATB2, and CSF1 ISH, with no staining for urothelial markers or pankeratin. Both MN and GC were negative for H3.G34W and HCG. Next-generation sequencing revealed mutations consistent with conventional urothelial carcinomas.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The distinct biphasic morphology, characteristic immunophenotype, and molecular findings of UCOGC suggest it is of urothelial origin, and we believe it justifies its classification as a unique subtype rather than under \u201cpoorly differentiated urothelial carcinoma.\u201d<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajcp\/aqaf044","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T09:58:47Z","timestamp":1749808727000},"page":"257-264","source":"Crossref","is-referenced-by-count":6,"title":["Urothelial carcinoma with osteoclast-like giant cells: An expanded immunohistochemical and molecular profile"],"prefix":"10.1093","volume":"164","author":[{"given":"Carol N","family":"Rizkalla","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington , Seattle, WA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tretiakova","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington , Seattle, WA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J","family":"Suarez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford Medical Center , Stanford, CA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3898-1460","authenticated-orcid":false,"given":"Sean R","family":"Williamson","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic , Cleveland, OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9890-8751","authenticated-orcid":false,"given":"Khaleel I","family":"Al-Obaidy","sequence":"additional","affiliation":[{"name":"Henry Ford Hospital , Detroit, MI ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres M","family":"Acosta","sequence":"additional","affiliation":[{"name":"Department of Pathology, Indiana University , Indianapolis, IN ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad T","family":"Idrees","sequence":"additional","affiliation":[{"name":"Department of Pathology, Indiana University , Indianapolis, IN ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford Medical Center , Stanford, CA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7948-2337","authenticated-orcid":false,"given":"Susan","family":"Potterveld","sequence":"additional","affiliation":[{"name":"University of Colorado, Department of Pathology , Aurora, CO ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur R","family":"Sangoi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford Medical Center , Stanford, CA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"2025082604521764500_CIT0001","volume-title":"(WHO Classification of Tumours Series, 5th ed.; vol. 8)","author":"WHO Classification of Tumours Editorial Board","year":"2022"},{"key":"2025082604521764500_CIT0002","volume-title":"(WHO Classification of Tumours Series, 4th ed.; vol. 8)","author":"WHO Classification of Tumours Editorial Board","year":"2016"},{"key":"2025082604521764500_CIT0003","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/PAS.0000000000000689","article-title":"Undifferentiated carcinoma with osteoclastic giant cells of the pancreas: clinicopathologic analysis of 38 cases highlights a more protracted clinical course than currently appreciated","volume":"40","author":"Muraki","year":"2016","journal-title":"Am J Surg Pathol."},{"key":"2025082604521764500_CIT0004","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41379-022-01112-9","article-title":"Breast carcinomas with osteoclast-like giant cells: a comprehensive clinico-pathological and molecular portrait and evidence of RANK-L expression","volume":"35","author":"Cyrta","year":"2022","journal-title":"Mod Pathol."},{"key":"2025082604521764500_CIT0005","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/modpathol.3800521","article-title":"Osteoclast-rich undifferentiated carcinomas of the urinary tract","volume":"19","author":"Baydar","year":"2006","journal-title":"Mod Pathol."},{"key":"2025082604521764500_CIT0006","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41379-018-0012-z","article-title":"An expanded immunohistochemical profile of osteoclast-rich undifferentiated carcinoma of the urinary tract","volume":"31","author":"Priore","year":"2018","journal-title":"Mod Pathol."},{"key":"2025082604521764500_CIT0007","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/ajcp\/aqad148","article-title":"Diagnostic impact of RNA-based next-generation sequencing fusion panel for solid tumors: a single-institution experience","volume":"161","author":"Fei","year":"2024","journal-title":"Am J Clin Pathol."},{"key":"2025082604521764500_CIT0008","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ymthe.2021.03.023","article-title":"Targeted replacement of full-length CFTR in human airway stem cells by CRISPR-Cas9 for pan-mutation correction in the endogenous locus","volume":"30","author":"Vaidyanathan","year":"2022","journal-title":"Mol Ther."},{"key":"2025082604521764500_CIT0009","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF00583591","article-title":"Giant cell tumor of the kidney","volume":"398","author":"Kimura","year":"1983","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"2025082604521764500_CIT0010","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1365-2559.1987.tb02646.x","article-title":"Malignant osteoclastoma-like giant cell tumour of the renal pelvis","volume":"11","author":"Borg-Grech","year":"1987","journal-title":"Histopathology."},{"key":"2025082604521764500_CIT0011","doi-asserted-by":"publisher","first-page":"154164","DOI":"10.1016\/j.prp.2022.154164","article-title":"The osteoclast-type giant cell rich carcinoma of urinary bladder: a case series","volume":"239","author":"Satturwar","year":"2022","journal-title":"Pathol Res Pract."},{"key":"2025082604521764500_CIT0012","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1158\/1078-0432.CCR-22-1898","article-title":"Interactions in CSF1-driven tenosynovial giant cell tumors","volume":"28","author":"van IJzendoorn","year":"2022","journal-title":"Clin Cancer Res."},{"key":"2025082604521764500_CIT0013","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/PAS.0b013e3181a8ffbe","article-title":"Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture","volume":"33","author":"Cox","year":"2009","journal-title":"Am J Surg Pathol."},{"key":"2025082604521764500_CIT0014","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2021.05.010","article-title":"RNAscope CSF1 chromogenic in situ hybridization: a potentially useful tool in the differential diagnosis of tenosynovial giant cell tumors","volume":"115","author":"Thangaiah","year":"2021","journal-title":"Hum Pathol."},{"key":"2025082604521764500_CIT0015","doi-asserted-by":"publisher","first-page":"2724948","DOI":"10.1155\/2019\/2724948","article-title":"CSF-1 overexpression predicts poor prognosis in upper tract urothelial carcinomas","volume":"2019","author":"Hsu","year":"2019","journal-title":"Dis Markers."},{"key":"2025082604521764500_CIT0016","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13000-022-01266-9","article-title":"Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue","volume":"17","author":"Sugita","year":"2022","journal-title":"Diagn Pathol."},{"key":"2025082604521764500_CIT0017","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/03008207.2013.848202","article-title":"Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone","volume":"54","author":"Lau","year":"2013","journal-title":"Connect Tissue Res."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/2\/257\/63484478\/aqaf044.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/2\/257\/63484478\/aqaf044.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T08:52:24Z","timestamp":1756198344000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/164\/2\/257\/8161578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6,13]]},"published-print":{"date-parts":[[2025,8,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaf044","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,6,13]]}}}